(Q42909091)

10 November 2017

In vitro study of Candida tropicalis isolates exhibiting paradoxical growth in the presence of high concentrations of caspofungin (English)

1 reference

10 November 2017

Candida tropicalis

1 reference

5

1 reference

10 November 2017

G Sóczó

1

1 reference

10 November 2017

G Kardos

2

1 reference

10 November 2017

I Varga

3

1 reference

10 November 2017

B Kelentey

4

1 reference

10 November 2017

L Majoros

6

1 reference

10 November 2017

language of work or name

English

0 references

publication date

8 October 2007

1 reference

Antimicrobial Agents and Chemotherapy

10 November 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 November 2017

51

1 reference

10 November 2017

12

1 reference

10 November 2017

4474-4476

1 reference

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

10 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

Assessment of the paradoxical effect of caspofungin in therapy of candidiasis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

Caspofungin susceptibility testing of Candida inconspicua: correlation of different methods with the minimal fungicidal concentration

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168010

16 August 2018

Identifiers

DOI

10.1128/AAC.00880-07

1 reference

10 November 2017

1 reference

10 November 2017

PubMed publication ID

17923496

1 reference